Kangbin Zhou


About the Students

E-mail: odinzhou@hotmail.com
Phone: 778-233-0833

Training

Degree: Bachelor of Science, Major Pharmacology 2009 (UBC)
Pharmacology Laboratory Skills:
  • Surgical preparation of isolated rat and guinea pig hearts
  • Surgical cannulation of anesthetized rats
  • Experience with conducting experiments involving various pharmacological agents
  • Data analysis of blood pressure, heart rate and ECG
  • Cardiomyocyte Isolation
Biochemistry Laboratory Skills:
  • SDS-PAGE gel electrophoresis
  • Western Blot
  • PCR

Current Position

First year in Master of Science Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences
  • Supervisor: Dr. John McNeill
  • Co-supervisor: TBA
Teaching Assistant For:
  • Pharmaceutical Sciences 471
  • Pharmaceutical Sciences 342 & 453B

Scholarships + Awards

Name: President’s Entrance Scholarship
Year: 2005
Name: J Fred Muir Memorial Scholarship in Science
Year: 2007
Name: Science Scholar/Dean’s Honour List
Year: 2006-2007
Name: Dean’s Honour List
Year: 2007-2008
Name: Golden Key Membership
Year: 2008 - present
Name: Graduate Entrance Scholarship
Year: 2009-2010
Name: International Partial Tuition Scholarship
Year: 2009-2010
Name: Faculty of Pharmaceutical Sciences Graduate Award
Year: 2009-2010

 

About the Research

The objective of the current research is to investigate the effects of phentolamine, a non-selective α adrenergic antagonist, on the hypertensive condition in fructose fed rats (FFRs). Wistar rats will be used as the model, which will be divided into four groups: control, control treated (with phentolamine), fructose fed, fructose fed treated. Plasma norepinephrine and angiotensin II level will be measured to evaluate the interaction between sympathetic nervous system (SNS) and rennin-angiontensin system (RAS).

These results will be compared to those obtained by a previous student Linda Tran who investigated the effects of prazosin, which is a α1 selective blocker, in order to indirectly evaluate the involvement of α2 receptors in hypertension. Insulin sensitivity will be measured and compared to that obtained by Tran, to validate the proposed relationship between β1 receptor activation and insulin resistance, since phentolamine, compared to prazosin, activates more β1 receptors. The direct measurement of α2 receptor activities in FFRs is currently being discussed. An in vitro study involving clonidine and yohimbine, a α2 selective agonist and antagonist, respectively, might be performed on blood vessels from FFRs to validate the current literature.

 

« Back



a place of mind, The University of British Columbia

Faculty of Pharmaceutical Sciences
2405 Wesbrook Mall
Vancouver, BC, Canada V6T 1Z3
Tel (Dean’s Office): 604.822.2343

Emergency Procedures | Accessibility | Contact UBC | © Copyright The University of British Columbia